Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2002-02-08
2004-11-09
Berch, Mark L. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C540S504000
Reexamination Certificate
active
06815543
ABSTRACT:
FIELD OF THE INVENTION
The study of drug metabolism is an important part of the very expensive drug R&D process. In humans and other mammals, many drugs are metabolized through oxidative reactions catalyzed by heme- and cytochrome-containing enzymes. Cytochrome P450 mono-oxygenases, the main enzymes involved in drug oxidative metabolism, have in their active site a heme moiety.
Synthetic metalloporphyrins can serve favorably to mimic oxidative catalytic reactions occurring in biological systems, with the aim of producing and identifying oxidative products of drug candidates, in quantities allowing in vivo studies.
PCT application WO 90/08455 discloses a process for the preparation of oxidative products using various combinations of a synthetic metalloporphyrin, a co-oxidizing reagent, and a solvent. The solvent is generally a CH
3
CN/CH
2
Cl
2
combination. One of the major inconveniences of processes of this type is the fact that they frequently provide incomplete yields of the sought-after individual products as well as low conversion percentages. As a result, they can rarely be used in a reliable fashion in integrated discovery processes. In fact, their use is generally limited to experimental validation.
SUMMARY OF THE INVENTION
In accordance with the present invention, the inventor has unexpectedly found that the yields of oxidative reactions involving metalloporphyrins and which can be useful for the synthesis of metabolites of organic compounds of interest could be increased in a substantial manner through the use of an inert aprotic solvent.
Thus, one of the objects of the present invention is a process for the oxidation of organic compounds. This process comprises reacting the selected organic compound with catalytic amounts of a metalloporphyrin and of an oxidizing agent in the presence of an inert aprotic solvent and recovering the desired products obtained therefrom.
The process of the invention is extremely useful in pharmaceutical research and development as it can be used to perform preliminary evaluations of the metabolic processes which are likely to occur when a given compound is tested in vivo. These preliminary evaluations can be performed rapidly without having to carry out expensive and time consuming in vivo experiments. Furthermore, the process of the present invention provides better yields of individual products than those obtained using prior art processes. In other words, the process of the present invention opens the possibility of obtaining and analyzing in a more systematic fashion a higher number of individual potential metabolites for a given selected compound on which the process is carried out.
REFERENCES:
patent: 4101334 (1991-08-01), None
patent: 0342615 (1989-11-01), None
patent: WO 96 08455 (1996-03-01), None
(Battoni et al. Laboratoire de Chimie et Biochimie Pharmacoloques et Toxicologiques, Univ. Rene Descartes, Paris, Fr., Act. Dioxygen Homogeneous Catal. Oxid [Proc. Int. Symp], 5th (1993), 449.*
Yoon Jing Lee, Epoxidation of Olefins with H202 Catalyzed By An Electronegatively-substituted Iron Pdorphyrin Complex In Aprotic Solvent, Chemistry Letters, No. 8, pp. 837-838 (1998).
Still, et al., Rapid Chromatographic Technique for Preparative Separation with Moderate Resolution, J. Org. Chem, 43: 2923 (1978).
Felix, et al., Quinazolines and 1,4-Benzodiazepines. XLIII(1). Oxidations with Ruthenium Tetroxide, J. Heterocycl. Chem, 5: 731 (1968).
Sulkowski, et al., The Formation and Subsequent Rearrangment of 7-Chloro-5-phenyl-3,1,4-benzoxadiazepin-2(1H)-one, J. Org. Chem., 27: 4424 (1962).
Battioni, et al., Monooxygenase-like Oxidation of Hydrocarbons by H202 Catalyzed by Manganese Porphyrins and Imidazole: Selection of the Best Catalytic System and Nature of the Active Oxygen Species, J. Am. Chem. Soc., 110: 8462 (1988).
Thellend, et al., Ammonium Acetate as a very Sime and Efficient Cocatalyst for Manganese Prophyrin-catalysed Oxgenation of Hydroarbons by Hydrogetn Peroxide, J. Chem. Soc., Chem. Comm., 1035 (1994).
Ebel, V.S., et al., Analytik und Synthese wichtiger 3-Hydroxy-5-phenyl-1,4-benzodiazepin-2-on-Derivate, Arzneim.-Forsch., 29:1317 (1979).
Rocha Gonsalves, et al., State of the art in the development of biomimetic oxidation catalysts, J. Mol. Catal. A: Chem., 113:209 (1996).
Frohlic, L. et al., Moglichkeiten des Einsatze biomimetischer System zur Monooxygenierung von Wirk-und Arzneistoffen, Pharm. Ind. 59:803 (1997).
Chorghade, M.S., et al., Metalloporphyrins as chemical mimics of cytochrome P-450 systems, Pure Appl. Chem. 68:753 (1996).
Meunier, B., Metalloporphyrins and Versatile Catalysts for Oxidation Reactions and Oxidative DNA Cleavage, Chem Rev., 92:1411 (1992).
Masumoto, H., Applications of Chemical Cytochrome P-450 Model Systems to Studies On Drug Metabolism, M. Drug Metab. Dispos, 19:768 (1991).
Seddon, T., et al., Comparative Drug Metabolism of Diazepam in Hepatocytes Isolated From Man, Rat, Monkey and Dog, Biochem. Phjarmacol., 38:1657 (1989).
Chenery, R.J., et al., Diazepam Metabolism in Cultured Hepatocytes from Rat, Rabbit, Dog, Guinea Pig, and Man, R. Drug Metab. Dispo., 15:312 (1987).
Andrews, S.M., et al., The metabolism and disposition of [2-14C]diazepam in the streptozotocin-diabetic rat, Xenobitica 14:751 (1984).
Schwandt, H.J., et al., Metabolic Rearrangements of 1,4-Benzodiazepine Derivatices, Xenobiotica 4:733 (1974).
Ruelius, H.W., et al., Metabolism of Diazepam in Dogs: Transformation to Oxazepam, Arch. Biochem. Biophys., III:376 (1965).
Schwartz, M.A., et al., Metabolism of Diazepam in Rat, Dog, and Man, J. Pharmacol. Exp. Ther., 149:423 (1965).
Ogawa, A., et al., Benzotrifluoride: A Useful Alternative Solvent for Organic Reactions Currently Conducted in Dichloromethane and Related Solvents, J. Org. Chem., 62:450 (1997).
Ono, S., et al., Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily, Xenobiotica, 26:1155 (1996).
Dolphin D., et al., Polyhaloporphyrins: Usual Ligands for Metals and Metal-Catalyzed Oxidations, Acc. Chem. Res., 30:251 (1997).
Berch Mark L.
Habte Kahsay
Purchase, Jr. Claude F.
Russo Matthew
Warner-Lambert & Company
LandOfFree
Process for catalyzing the oxidation of organic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for catalyzing the oxidation of organic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for catalyzing the oxidation of organic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3319724